日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE

在TENAYA/LUCERNE研究中,法瑞西单抗与阿柏西普2 mg头对头给药比较显示,色素上皮脱离厚度降低。

Lim, Jennifer I; Ambresin, Aude; Avery, Robert L; Chaikitmongkol, Voraporn; Eter, Nicole; Gomi, Fumi; Khanani, Arshad M; London, Nikolas J S; Harrell, Emma; Margaron, Philippe; Patel, Shriji; Souverain, Audrey; Yang, Ming; Lai, Timothy Y Y

Effect of Finerenone in Cardiovascular and Renal Outcomes: A Systematic Review and Meta-analysis

非奈利酮对心血管和肾脏结局的影响:系统评价和荟萃分析

Rivera-Martinez, Juan Carlos; Sabina, Michael; Khanani, Aqeel; Lurie, Andrew; Rigdon, Amanda; Abusnina, Waiel; Lugo Rosado, Luis Daniel; Bizanti, Anas; Paul, Timir K

AI in Mental Health: Transforming Diagnosis and Management of Depression and Anxiety

人工智能在心理健康领域的应用:变革抑郁症和焦虑症的诊断与治疗

Kambar, Tilyan; Tariq, Sara; Shahzad, Saman; Sultan, Hajra Sana; Siddiqui, Araj Naveed; Shah, Fakiha Ahmed; Khanani, Hamna; Khan, Ayesha; Shah, Hussain Haider; Rauf, Sameer Abdul; Zuberi, Muhammad Abdul Wasay; Waseem, Radeyah; Hussain, Muhammad Sheheryar; Haque, Md Ariful

A novel modifier gene therapy to treat Stargardt disease: Phase 1 GARDian1 Trial Insights

一种治疗斯塔加特病的新型修饰基因疗法:GARDian1 一期试验结果

Khanani, Arshad M; Vajzovic, Lejla; Bakall, Benjamin; Chavali, Venkata Ramana Murthy; Qamar, Huma

Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis

法瑞西单抗治疗初治新生血管性年龄相关性黄斑变性伴视网膜下出血患者的视觉和解剖学结果:一项多中心回顾性分析

Sivachandran, Nirojini; Ji, Patrick Xiang; Khan, Hannah; Pickel, Lauren; Mojumder, Ohidul; Aziz, Aamir A; Khan, Huma; Sulahria, Humza; Gahn, Greggory M; Khanani, Arshad M

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial

持续使用端口输注系统给予雷珠单抗与每月一次给予雷珠单抗治疗糖尿病性黄斑水肿:宝塔随机临床试验

Khanani, Arshad M; Campochiaro, Peter A; Graff, Jordan M; Marcus, Dennis M; Miller, Daniel; Mittra, Robert A; Regillo, Carl; Sheth, Veeral S; Bobbala, Ashwini; Gune, Shamika; Lin, Stephanie; Quezada-Ruiz, Carlos; Malhotra, Varun

Phase I Study of the Anti-interleukin 33 Fragment Antigen-Binding Region RO7303359 in Geographic Atrophy Secondary to Age-Related Macular Degeneration

抗白细胞介素33片段抗原结合区RO7303359治疗继发于年龄相关性黄斑变性的地图状萎缩的I期研究

Pearlman, Joel A; Sheth, Veeral S; Khanani, Arshad M; Indjeian, Vahan B; Brunstein, Flavia; Kuruvilla, Denison; Maia, Mauricio; Dere, Randall; Ma, Ling; Chen, Hao; Datta, Seema; Willis, Jeffrey R; Wiley, Henry E

Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis

索奈柏西普(抗 VEGF-C/-D)联合雷珠单抗治疗息肉状脉络膜血管病:IIb 期预定义亚组分析

Cheung, Chui Ming Gemmy; Jackson, Timothy L; Wykoff, Charles C; Khanani, Arshad M; Leitch, Ian M; Baldwin, Megan E; Slakter, Jason

Impact of Uptake Period on (18)F-DCFPyL-PSMA PET/CT Maximum Standardised Uptake Value

摄取期对 (18)F-DCFPyL-PSMA PET/CT 最大标准化摄取值的影响

Nassour, Anthony-Joe; Jain, Anika; Khanani, Hadia; Hui, Nicholas; Thompson, Nadine J; Sorensen, Brian; Baskaranathan, Sris; Bergersen, Philip; Chalasani, Venu; Dean, Thomas; Dias, Max; Wines, Michael; Symons, James; Tarlinton, Lisa; Woo, Henry

Differential Visual Outcomes in Neovascular AMD Based on Ellipsoid Zone Integrity and Fluid Presence: Insights from a Phase III Trial

基于椭圆体区完整性和液体存在情况的新生血管性年龄相关性黄斑变性患者视觉结局差异:来自 III 期试验的启示

Ehlers, Justis P; Yordi, Sari; Cetin, Hasan; Amine, Reem; Matar, Karen; Indurkar, Asmita; Talcott, Katherine E; Kaiser, Peter K; Khanani, Arshad M; Hu, Joanne; Srivastava, Sunil K